disease - GeniusWindow

FDA Approves First AI Tool AIM-NASH to Advance Liver Disease Trials

12 December 2025 by GeniusWindow

First AI Tool to Advance Liver Disease Trials

The U.S. Food and Drug Administration has reached a groundbreaking regulatory milestone by officially qualifying AIM-NASH as the world’s first AI-based drug development tool for assessing metabolic dysfunction-associated steatohepatitis (MASH), a severe and progressive type of fatty liver disease. This qualification marks one of the significant milestones in the integration of artificial intelligence into clinical … Read more

Guillain-Barré syndrome

27 January 202527 January 2025 by GeniusWindow

Recently, more than 100 cases of Guillain-Barré syndrome have been reported in Pune, Maharashtra. The syndrome is named after the French neurologists Georges Guillian and Jean Alexandre Barré, who together with French physician André Strohl, identified it in 1916. In this condition, the body’s immune system attacks the nervous system. ALSO READ- World Malaria Report … Read more